{"id":"https://openalex.org/W4385076561","doi":"https://doi.org/10.1016/j.jcyt.2023.06.007","title":"Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG)","display_name":"Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG)","publication_year":2023,"publication_date":"2023-07-22","ids":{"openalex":"https://openalex.org/W4385076561","doi":"https://doi.org/10.1016/j.jcyt.2023.06.007","pmid":"https://pubmed.ncbi.nlm.nih.gov/37486281"},"language":"en","primary_location":{"id":"doi:10.1016/j.jcyt.2023.06.007","doi":"https://doi.org/10.1016/j.jcyt.2023.06.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcyt.2023.06.007","pdf_url":"http://www.isct-cytotherapy.org/article/S1465324923009842/pdf","source":{"id":"https://openalex.org/S36838616","display_name":"Cytotherapy","issn_l":"1465-3249","issn":["1465-3249","1477-2566"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cytotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.isct-cytotherapy.org/article/S1465324923009842/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008694549","display_name":"Rishu Takimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]},{"id":"https://openalex.org/I4405286243","display_name":"Juntendo Advanced Research Institute for Health Science","ror":"https://ror.org/01kbm8v50","country_code":"JP","type":"facility","lineage":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Rishu Takimoto","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan. Electronic address: takimoto@j-immunother.com","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","LSI Sapporo Clinic, Sapporo, Japan","Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan. Electronic address: takimoto@j-immunother.com","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan","institution_ids":[]},{"raw_affiliation_string":"Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083431844","display_name":"Takashi Kamigaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]},{"id":"https://openalex.org/I4405286243","display_name":"Juntendo Advanced Research Institute for Health Science","ror":"https://ror.org/01kbm8v50","country_code":"JP","type":"facility","lineage":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Kamigaki","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103275712","display_name":"Hisao Ito","orcid":"https://orcid.org/0009-0003-0326-903X","observed_orcids":["https://orcid.org/0009-0003-0326-903X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hisao Ito","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0009-0003-0326-903X","affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050400255","display_name":"M Saito","orcid":"https://orcid.org/0009-0003-6439-3237","observed_orcids":["https://orcid.org/0009-0003-6439-3237"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masashi Saito","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0009-0003-6439-3237","affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112048602","display_name":"Ken Takizawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ken Takizawa","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012338301","display_name":"Kenzo Soejima","orcid":"https://orcid.org/0000-0001-9749-995X","observed_orcids":["https://orcid.org/0000-0001-9749-995X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenzo Soejima","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0001-9749-995X","affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075271142","display_name":"Hiroyuki Yasuda","orcid":"https://orcid.org/0000-0001-9966-8569","observed_orcids":["https://orcid.org/0000-0001-9966-8569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroyuki Yasuda","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044209101","display_name":"Keiko Ohgino","orcid":"https://orcid.org/0000-0002-8280-447X","observed_orcids":["https://orcid.org/0000-0002-8280-447X","https://orcid.org/0009-0005-7079-3557"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keiko Ohgino","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0002-8280-447X","affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050539627","display_name":"Hideki Terai","orcid":"https://orcid.org/0000-0002-1118-1930","observed_orcids":["https://orcid.org/0000-0002-1118-1930"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideki Terai","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0002-1118-1930","affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109087101","display_name":"Katsuro Tomita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuro Tomita","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082660170","display_name":"Miyabi Miura","orcid":"https://orcid.org/0000-0002-9922-0155","observed_orcids":["https://orcid.org/0000-0002-9922-0155"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Miyabi Miura","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043073600","display_name":"Eishiro Mizukoshi","orcid":"https://orcid.org/0000-0002-2036-9599","observed_orcids":["https://orcid.org/0000-0002-2036-9599"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eishiro Mizukoshi","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075738891","display_name":"Tomoharu Miyashita","orcid":"https://orcid.org/0000-0002-3771-0773","observed_orcids":["https://orcid.org/0000-0002-3771-0773"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoharu Miyashita","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090827058","display_name":"Yasunari Nakamoto","orcid":"https://orcid.org/0000-0002-3160-3555","observed_orcids":["https://orcid.org/0000-0002-3160-3555"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasunari Nakamoto","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028483263","display_name":"Katsuhiro Hayashi","orcid":"https://orcid.org/0000-0001-8665-2154","observed_orcids":["https://orcid.org/0000-0001-8665-2154"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuhiro Hayashi","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010692199","display_name":"Shinji Miwa","orcid":"https://orcid.org/0000-0002-5962-8287","observed_orcids":["https://orcid.org/0000-0002-5962-8287"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinji Miwa","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":"https://orcid.org/0000-0002-5962-8287","affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masaaki Kitahara","orcid":"https://orcid.org/0000-0003-3053-4356","observed_orcids":["https://orcid.org/0000-0003-3053-4356"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaaki Kitahara","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":"https://orcid.org/0000-0003-3053-4356","affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088078553","display_name":"Akihiko Takeuchi","orcid":"https://orcid.org/0000-0002-4071-5620","observed_orcids":["https://orcid.org/0000-0002-4071-5620"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihiko Takeuchi","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":"https://orcid.org/0000-0002-4071-5620","affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018349469","display_name":"Hiroaki J. Kimura","orcid":"https://orcid.org/0000-0002-7441-0382","observed_orcids":["https://orcid.org/0000-0002-7441-0382"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Kimura","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103259828","display_name":"Takafumi Mochizuki","orcid":"https://orcid.org/0009-0001-6215-2769","observed_orcids":["https://orcid.org/0009-0001-6215-2769"]},"institutions":[{"id":"https://openalex.org/I4210091496","display_name":"Kanazawa Medical Center","ror":"https://ror.org/00m8tc820","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210091496","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takafumi Mochizuki","raw_affiliation_strings":["Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kanazawa Advanced Medical Center, Kanazawa City, Japan"],"raw_orcid":"https://orcid.org/0009-0001-6215-2769","affiliations":[{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kanazawa Advanced Medical Center, Kanazawa City, Japan","institution_ids":["https://openalex.org/I4210091496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073919939","display_name":"Hiroki Sugie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroki Sugie","raw_affiliation_strings":["LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","LSI Sapporo Clinic, Sapporo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025136502","display_name":"Ken-Ichiro Seino","orcid":"https://orcid.org/0000-0003-4122-1718","observed_orcids":["https://orcid.org/0000-0003-4122-1718"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ken-ichiro Seino","raw_affiliation_strings":["LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","LSI Sapporo Clinic, Sapporo, Japan"],"raw_orcid":"https://orcid.org/0000-0003-4122-1718","affiliations":[{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102537248","display_name":"Tomonori Yamada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomonori Yamada","raw_affiliation_strings":["LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","LSI Sapporo Clinic, Sapporo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060431088","display_name":"Syuhei Takeuchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Syuhei Takeuchi","raw_affiliation_strings":["LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","LSI Sapporo Clinic, Sapporo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"LSI Sapporo Clinic, Sapporo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041557043","display_name":"Kaori Makita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255024","display_name":"Takaoka City Hospital","ror":"https://ror.org/02h2fg990","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255024"]},{"id":"https://openalex.org/I4405257207","display_name":"Matsusaka City Hospital","ror":"https://ror.org/050wvyk52","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405257207"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kaori Makita","raw_affiliation_strings":["Kitaosaka Medical Clinic, Suita City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Kitaosaka Medical Clinic, Suita City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kitaosaka Medical Clinic, Suita City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Kitaosaka Medical Clinic, Suita City, Japan","institution_ids":["https://openalex.org/I4405255024","https://openalex.org/I4405257207"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056138720","display_name":"Keiko Naitoh","orcid":"https://orcid.org/0009-0002-4913-3261","observed_orcids":["https://orcid.org/0009-0002-4913-3261"]},"institutions":[{"id":"https://openalex.org/I4210149284","display_name":"Saiseikai Fukuoka General Hospital","ror":"https://ror.org/05c8e3213","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210149284"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiko Naitoh","raw_affiliation_strings":["Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Fukuoka Medical Clinic, Fukuoka City, Japan"],"raw_orcid":"https://orcid.org/0009-0002-4913-3261","affiliations":[{"raw_affiliation_string":"Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":["https://openalex.org/I4210149284"]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Fukuoka Medical Clinic, Fukuoka City, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052578079","display_name":"Kosei Yasumoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149284","display_name":"Saiseikai Fukuoka General Hospital","ror":"https://ror.org/05c8e3213","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210149284"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kosei Yasumoto","raw_affiliation_strings":["Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Fukuoka Medical Clinic, Fukuoka City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":["https://openalex.org/I4210149284"]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Fukuoka Medical Clinic, Fukuoka City, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046900502","display_name":"Yoichiro Yoshida","orcid":"https://orcid.org/0000-0001-6583-7352","observed_orcids":["https://orcid.org/0000-0001-6583-7352"]},"institutions":[{"id":"https://openalex.org/I4210149284","display_name":"Saiseikai Fukuoka General Hospital","ror":"https://ror.org/05c8e3213","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210149284"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoichiro Yoshida","raw_affiliation_strings":["Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Fukuoka Medical Clinic, Fukuoka City, Japan"],"raw_orcid":"https://orcid.org/0000-0001-6583-7352","affiliations":[{"raw_affiliation_string":"Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":["https://openalex.org/I4210149284"]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Fukuoka Medical Clinic, Fukuoka City, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068560615","display_name":"Hiroyuki Inoue","orcid":"https://orcid.org/0000-0002-8071-8797","observed_orcids":["https://orcid.org/0000-0002-8071-8797"]},"institutions":[{"id":"https://openalex.org/I4210149284","display_name":"Saiseikai Fukuoka General Hospital","ror":"https://ror.org/05c8e3213","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210149284"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Inoue","raw_affiliation_strings":["Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Fukuoka Medical Clinic, Fukuoka City, Japan"],"raw_orcid":"https://orcid.org/0000-0002-8071-8797","affiliations":[{"raw_affiliation_string":"Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":["https://openalex.org/I4210149284"]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Fukuoka Medical Clinic, Fukuoka City, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104016952","display_name":"Katsuhiro Kotake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800476646","display_name":"Nagoya City Science Museum","ror":"https://ror.org/04m2ybb32","country_code":"JP","type":"archive","lineage":["https://openalex.org/I2800476646"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuhiro Kotake","raw_affiliation_strings":["Masuko Memorial Hospital, Nagoya City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Masuko Memorial Hospital, Nagoya City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Masuko Memorial Hospital, Nagoya City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Masuko Memorial Hospital, Nagoya City, Japan","institution_ids":["https://openalex.org/I2800476646"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080312202","display_name":"Kihachi Ohshima","orcid":"https://orcid.org/0000-0002-1569-5824","observed_orcids":["https://orcid.org/0000-0002-1569-5824"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kihachi Ohshima","raw_affiliation_strings":["Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Heisei-Hidaka Clinic, Gunma, Japan"],"raw_orcid":"https://orcid.org/0000-0002-1569-5824","affiliations":[{"raw_affiliation_string":"Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Heisei-Hidaka Clinic, Gunma, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011364641","display_name":"Shin\u2010ei Noda","orcid":"https://orcid.org/0000-0002-0016-3251","observed_orcids":["https://orcid.org/0000-0002-0016-3251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shin-ei Noda","raw_affiliation_strings":["Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Heisei-Hidaka Clinic, Gunma, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0016-3251","affiliations":[{"raw_affiliation_string":"Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Heisei-Hidaka Clinic, Gunma, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024701320","display_name":"Masahiko Okamoto","orcid":"https://orcid.org/0000-0002-8787-3298","observed_orcids":["https://orcid.org/0000-0002-8787-3298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masahiko Okamoto","raw_affiliation_strings":["Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Heisei-Hidaka Clinic, Gunma, Japan"],"raw_orcid":"https://orcid.org/0000-0002-8787-3298","affiliations":[{"raw_affiliation_string":"Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Heisei-Hidaka Clinic, Gunma, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006602926","display_name":"Yuya Yoshimoto","orcid":"https://orcid.org/0000-0002-4967-6736","observed_orcids":["https://orcid.org/0000-0002-4967-6736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuya Yoshimoto","raw_affiliation_strings":["Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Heisei-Hidaka Clinic, Gunma, Japan"],"raw_orcid":"https://orcid.org/0000-0002-4967-6736","affiliations":[{"raw_affiliation_string":"Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Heisei-Hidaka Clinic, Gunma, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046543589","display_name":"Sachiko Okada","orcid":"https://orcid.org/0000-0002-2900-1010","observed_orcids":["https://orcid.org/0000-0002-2900-1010"]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]},{"id":"https://openalex.org/I4405286243","display_name":"Juntendo Advanced Research Institute for Health Science","ror":"https://ror.org/01kbm8v50","country_code":"JP","type":"facility","lineage":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Sachiko Okada","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0002-2900-1010","affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018661226","display_name":"Hiroshi Ibe","orcid":"https://orcid.org/0009-0002-2114-9368","observed_orcids":["https://orcid.org/0009-0002-2114-9368"]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]},{"id":"https://openalex.org/I4405286243","display_name":"Juntendo Advanced Research Institute for Health Science","ror":"https://ror.org/01kbm8v50","country_code":"JP","type":"facility","lineage":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Ibe","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0009-0002-2114-9368","affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004583152","display_name":"Eri Oguma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]},{"id":"https://openalex.org/I4405286243","display_name":"Juntendo Advanced Research Institute for Health Science","ror":"https://ror.org/01kbm8v50","country_code":"JP","type":"facility","lineage":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eri Oguma","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103343791","display_name":"Shigenori Goto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]},{"id":"https://openalex.org/I4405286243","display_name":"Juntendo Advanced Research Institute for Health Science","ror":"https://ror.org/01kbm8v50","country_code":"JP","type":"facility","lineage":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigenori Goto","raw_affiliation_strings":["Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","Seta Clinic Group, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"]},{"raw_affiliation_string":"Seta Clinic Group, Tokyo, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5008694549"],"corresponding_institution_ids":["https://openalex.org/I34077901","https://openalex.org/I4405286243"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":{"value":3300,"currency":"USD","value_usd":3300},"fwci":0.6016,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.63531483,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"25","issue":"11","first_page":"1229","last_page":"1235"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.5327000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.5327000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.225600004196167,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.21119999885559082,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-cell-therapy","display_name":"immune cell therapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cancer-immunotherapy-safety","display_name":"cancer immunotherapy safety","score":0.734000027179718},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9319999814033508},{"id":"https://openalex.org/keywords/dendritic-cell-vaccine","display_name":"dendritic cell vaccine","score":0.7459999918937683},{"id":"https://openalex.org/keywords/nk-cell-therapy","display_name":"NK cell therapy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.9259999990463257},{"id":"https://openalex.org/keywords/performance-status","display_name":"performance status","score":0.5740000009536743},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.4269999861717224},{"id":"https://openalex.org/keywords/fever","display_name":"fever","score":0.3580000102519989},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.7979999780654907},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.3869999945163727},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.3059999942779541},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.38100001215934753},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.41499999165534973}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7527703046798706},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.6584091186523438},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.5698752999305725},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5584582090377808},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5108780264854431},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49112817645072937},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.44347450137138367},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4394092857837677},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35535335540771484},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35434842109680176},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16863393783569336},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jcyt.2023.06.007","doi":"https://doi.org/10.1016/j.jcyt.2023.06.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcyt.2023.06.007","pdf_url":"http://www.isct-cytotherapy.org/article/S1465324923009842/pdf","source":{"id":"https://openalex.org/S36838616","display_name":"Cytotherapy","issn_l":"1465-3249","issn":["1465-3249","1477-2566"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cytotherapy","raw_type":"journal-article"},{"id":"pmid:37486281","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37486281","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cytotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jcyt.2023.06.007","doi":"https://doi.org/10.1016/j.jcyt.2023.06.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcyt.2023.06.007","pdf_url":"http://www.isct-cytotherapy.org/article/S1465324923009842/pdf","source":{"id":"https://openalex.org/S36838616","display_name":"Cytotherapy","issn_l":"1465-3249","issn":["1465-3249","1477-2566"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cytotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G5179371165","display_name":"Fundamental research for the development of novel cancer immunotherapy by elucidating multicellular interactions in hepatocellular carcinoma","funder_award_id":"21H02899","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385076561.pdf","grobid_xml":"https://content.openalex.org/works/W4385076561.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1790441981","https://openalex.org/W1892923309","https://openalex.org/W2004709238","https://openalex.org/W2020322537","https://openalex.org/W2049553585","https://openalex.org/W2084112669","https://openalex.org/W2103822734","https://openalex.org/W2103959341","https://openalex.org/W2124427232","https://openalex.org/W2186974291","https://openalex.org/W2333331522","https://openalex.org/W2417725200","https://openalex.org/W2464958310","https://openalex.org/W2496704236","https://openalex.org/W2586733270","https://openalex.org/W2734967882","https://openalex.org/W2773643507","https://openalex.org/W2811235175","https://openalex.org/W2966610462","https://openalex.org/W2976300082","https://openalex.org/W3016381127","https://openalex.org/W3016447165","https://openalex.org/W3046651482","https://openalex.org/W3106005610","https://openalex.org/W3139779297","https://openalex.org/W3160283912","https://openalex.org/W3185192286","https://openalex.org/W4200454749","https://openalex.org/W4211109310","https://openalex.org/W4288451368","https://openalex.org/W4306921237","https://openalex.org/W6717116468"],"related_works":["https://openalex.org/W1892923309","https://openalex.org/W4410804083","https://openalex.org/W3030783888","https://openalex.org/W4412826961","https://openalex.org/W2947947472","https://openalex.org/W4308375766","https://openalex.org/W4412530139","https://openalex.org/W2800978895","https://openalex.org/W6983274984","https://openalex.org/W3030742570"],"abstract_inverted_index":{"BACKGROUND":[0],"AIMS:":[1],"With":[2],"the":[3,7,27,71,79,132,147,276,285,343,348],"aim":[4],"of":[5,10,81,94,109,119,152,159,168,177,180,185,188,194,197,205,217,242,266,287,345],"strengthening":[6],"scientific":[8],"evidence":[9],"immune-cell":[11,76,103,260],"therapy":[12,77,190,201,214,236,261,353],"for":[13,146,227,347,354],"cancer":[14,355],"and":[15,49,61,84,115,135,192,251,306,323],"further":[16],"examining":[17],"its":[18],"safety,":[19],"in":[20,155,269],"October":[21],"2015,":[22],"our":[23,87],"hospital":[24],"jointly":[25],"established":[26],"Cancer":[28],"Immune-Cell":[29],"Therapy":[30],"Evaluation":[31],"Group":[32],"(CITEG)":[33],"with":[34,75,97,102,105,282,291],"39":[35],"medical":[36],"facilities":[37],"nationwide.":[38],"METHODS:":[39],"Medical":[40],"information,":[41],"such":[42],"as":[43],"patients'":[44,123],"background":[45],"characteristics,":[46],"clinical":[47],"efficacy":[48],"therapeutic":[50],"cell":[51,182,200,211,235],"types":[52],"obtained":[53],"from":[54],"each":[55],"facility,":[56],"has":[57],"been":[58],"accumulated,":[59],"analyzed":[60,70],"evaluated":[62],"by":[63,172,209],"CITEG.":[64],"In":[65,313],"this":[66,335],"prospective":[67],"study,":[68],"we":[69,85],"adverse":[72,164,169,206,243,267,280,298,318,365],"events":[73,170,207,244,268,319],"associated":[74,290],"until":[78],"end":[80],"September":[82],"2022,":[83],"presented":[86],"interim":[88],"safety":[89],"evaluation.":[90],"RESULTS:":[91],"A":[92],"total":[93,150],"3839":[95],"patients":[96,252,316],"malignant":[98],"tumor":[99],"were":[100,139,174,275,289,310,331],"treated":[101],"therapy,":[104,183],"a":[106,116,238,263,360],"median":[107],"age":[108],"64":[110,255],"years":[111],"(range,":[112],"13-97":[113],"years)":[114],"male-to-female":[117],"ratio":[118],"1:1.08":[120],"(1846:1993).":[121],"Most":[122],"performance":[124,246],"status":[125,247],"was":[126,157,215,222,339,356],"0":[127],"or":[128,141,249,258],"1":[129,248],"(86.8%)":[130],"at":[131,245],"first":[133],"visit,":[134],"3234":[136],"cases":[137],"(84.2%)":[138],"advanced":[140],"recurrent":[142],"cases,":[143],"which":[144,160,221,288],"accounted":[145],"majority.":[148],"The":[149,166,203],"number":[151,204],"administrations":[153,179,187,196,219],"reported":[154,279],"CITEG":[156],"31890,":[158],"960":[161],"(3.0%)":[162],"showed":[163],"events.":[165,366],"numbers":[167],"caused":[171,208],"treatment":[173,346,362],"363":[175],"(1.8%)":[176],"19661":[178],"\u03b1\u03b2T":[181,234],"9":[184],"845":[186],"\u03b3\u03b4T-cell":[189],"(1.1%)":[191],"10":[193],"626":[195],"natural":[198],"killer":[199],"(1.6%).":[202],"dendritic":[210],"(DC)":[212],"vaccine":[213,271,293],"578":[216],"10748":[218],"(5.4%),":[220],"significantly":[223,239],"larger":[224],"than":[225,254],"those":[226],"other":[228,297],"treatments.":[229],"Multivariate":[230],"analysis":[231],"revealed":[232],"that":[233,326],"had":[237,262,317],"greater":[240,264],"risk":[241,265],"higher,":[250],"younger":[253],"years,":[256],"women":[257],"adjuvant":[259],"DC":[270,292],"therapy.":[272,294],"Injection-site":[273],"reactions":[274],"most":[277],"frequently":[278,311],"events,":[281,284,299],"449":[283],"majority":[286],"Among":[295],"all":[296],"fever":[300],"(228":[301],"events),":[302],"fatigue":[303],"(141":[304],"events)":[305,309],"itching":[307],"(131":[308],"reported.":[312],"contrast,":[314],"three":[315],"(fever,":[320],"abdominal":[321],"pain":[322],"interstitial":[324],"pneumonia)":[325],"required":[327],"hospitalization,":[328],"although":[329],"they":[330],"weakly":[332],"related":[333],"to":[334,341,358],"therapy;":[336],"rather,":[337],"it":[338],"considered":[340,357],"be":[342,359],"effect":[344],"primary":[349],"disease.":[350],"CONCLUSIONS:":[351],"Immune-cell":[352],"safe":[361],"without":[363],"serious":[364]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-23T00:00:00"}